{"name":"Y's Therapeutics, Inc.","slug":"y-s-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWlJKTmotRGh3Y09LcTJySVlQaGwxM1NqZkkzN1c5UHZpbm4zVW9FNlc1QXMyZEJUSkJQdUdRc0FyaW1XakVaYWF6SEYzNUh6cnU2eWYzUEE4V2gzcXdPTnR5a3lySEZqYm16VjRuNmxDWFdpUGRiSmQ0NlJ4b1hXbW5pMGY2UFpzTjk3emV5YlNJbnlMS2lfQjNRWEZhdDJJNUwtYzJtTUFHWnRFclM5YnRULUM3eW9ENTltcXRTWXd0RTQ?oc=5","date":"2026-02-24","type":"earnings","source":"TradingView","summary":"AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales - TradingView","headline":"AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOcXQtazR5N3d3a0VjR082WXNKWUdtQVpyUFptZGJIT0Jma1NhT19RTGlQRTN3Tmh0ODhUWHB5Y282SDFxN3RYdVFOMjNFMUtIX1JQd3JLeFhQdWtyODRBaTU0ZDQ4cy1rUmRzdkNXRzBKZ3NZWE5sQkdZbXVhVThMbmx2WlRLTDdxcGpvMmFCTGFGS01CbzI3Nw?oc=5","date":"2026-02-23","type":"earnings","source":"finviz.com","summary":"Amicus' Q4 Earnings Miss, Higher Product Sales Drive Y/Y Revenues - finviz.com","headline":"Amicus' Q4 Earnings Miss, Higher Product Sales Drive Y/Y Revenues","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxPb19Ea0tMNzNqVUpmZmtQVkxZOVZIdjBMQXBBVDdFME5zdVlkNDYtOGpILTFvMTBiOWRNQTJDYVJVdkNUNXR0ZHV5WUl2QXVOZlhRbEMyYnZtbVh0X1Z6TDdlZkdzYUdkWnlJUjBtVnFzd1VjTlJTdkxlQ2oxMlY1NnpkV0VWcTJPVmRyZDJncUxHTTZmeTYtbGRHZTN3WjZIa0oxeFZDM0dmNndfaTBrX1JPWXhIZUZzc1QtbUJfVzZHanowNFBKaEVxLXJybDV0dkpnQkxnODJPVFdacEtmQUhNMXM3TmpRc1hLLXB6Z3NqaWtYbVR0Y1VZNVJtRU00U1hpQ1VyX2hjQWJWQ0tHN3ZEZ3JMR0QxQi1Ecjl4Z1p6eWhLbmw3VUdDcGt6Sm9lbC1JaERLaWtQaTFtUmx6QjRwLUNWeEJ1NWg3SlRIUTBUdlNVR0E?oc=5","date":"2025-09-18","type":"deal","source":"businesswire.com","summary":"VectorY Therapeutics and Shape Therapeutics Announce Option and License Agreement to Advance Vectorized Antibodies for Neurodegenerative Diseases Using an AAV5-Derived CNS Capsid - businesswire.com","headline":"VectorY Therapeutics and Shape Therapeutics Announce Option and License Agreement to Advance Vectorized Antibodies for N","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPM2ZTTHRYN201bjNKNkptLUtOSmpmV2o1ZlczcE91LW5FSktjTTJmNFZWVmU1YlRWREZweHE2Z0xhREtObjZrZl82VWtPTmJRMnB4aUhSTU1Ya2s4Mjg5Unh3RjV4NG53VWhjYVNaZkRHYWRhcmYteHF6blRtV0NBWmRjcHh0Q2ZBUGcyTjlRR1JUYkVyaVNmaTZIMmlVUHFzbGVIWTNxNjJnNTZkZVZfcnFwZU0xYmlBeDgwTFN4Ml9ScGdQd3lvWTQ0TEtrd181YW9Tc2hnajYtSHJfSHRKX3paTXlIMGNX?oc=5","date":"2025-09-17","type":"deal","source":"wsgr.com","summary":"Firm Advises Centerview Partners as Financial Advisor to Y-mAbs Therapeutics in Acquisition by SERB Pharmaceuticals - wsgr.com","headline":"Firm Advises Centerview Partners as Financial Advisor to Y-mAbs Therapeutics in Acquisition by SERB Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOSHF0UVNzeHIwN1E4SVFvZEJnRUZqNTluUTAyb29aM1NNdnplYjN3cGxienBmMlRFREZ1RDF0Nm1FMVV6Tnh6R0NaODJqNGczc3ZMMGJ5RWczY2VmX05pVXRpNi15cno2TDJhZnVub0xRZnFQaEcwZzE5WTFONVUtVi1zbDdJNkYxeGRBVjY5WmdzSzhyUnpmZUVZUUQ1UUtfNHE0NlBwNzI0Nnd0Z2lHSmE5QkI1dnhodWZpUXhOSjhwZFMxYkxCSGVhc25Xdkg4ZFI4?oc=5","date":"2025-09-16","type":"pipeline","source":"GlobeNewswire","summary":"SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics - GlobeNewswire","headline":"SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOVC1vN2lnQlBDZGFzM21ELVlNa04xMGVxc09ic0NJeEJqQzd5cEhVMlAwejVUVXFSWGtnM0NsR25HQ3h2SENRaGFubmNzMmF6TnI4cWZYaHNFckFzQ3J6Wm1kbHgwUXRTUjFBRzZMX3FVNkJzVFV3S3BBMW92YXpaWkNVdlM3TUUyb1Rucw?oc=5","date":"2025-08-12","type":"deal","source":"Yahoo Finance","summary":"Acquisition Deal Triggers Weekly Surge for Y-mAbs Therapeutics Stock - Yahoo Finance","headline":"Acquisition Deal Triggers Weekly Surge for Y-mAbs Therapeutics Stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxOR08wSHppb2RTNVcydkZrQXhxMU5ISEdaNXBLWXYwVzZmc0FMRG4xbXllekktcmk4S0k0OFlCbDNXWGQwMS0tcmtzS3VwVGk0cW5nNXZsNnVCS1dnSkgwSi1RZWxrNDFkc0ZEQ2c5OHhSSHo2YW90cFA5blhGMWY4eEdwWU14WE9pNFMzcFFaTlBUZzhXeHQ2UEhaVFJQZ180T0FLYjlVRGIwNGpqSVdPLU5mYVU2Q3YyTmFHR1dUV1Nib09IMkxuR1dHdDE1aXBqeElBVGFCcjVteG1NLTZIZjBUcEZuRVV2VmRlcDRPSQ?oc=5","date":"2025-08-07","type":"pipeline","source":"Mayer Brown","summary":"Mayer Brown advises the group Serb Pharmaceuticals on the structuring of the take-private of Y-mAb Therapeutics Inc. - Mayer Brown","headline":"Mayer Brown advises the group Serb Pharmaceuticals on the structuring of the take-private of Y-mAb Therapeutics Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQVmd2TFVpdF9LcEJ2b2ZuLTBjWU5nd1R0OHdvYlFLM0IxTjNiY3dXZVBMcEhCNmxubWk2c2pGS05MUk13NDA0ZTNzWUEwRzJ3Qm9Ic256ZzRnOVV5Zk5oUkUxM284Vk1jQTNScFlRQ1F5R1pJWjN6dzJ5TENDaHdfWU1LU1c5SDRJNTBwWjVaekRWZ2xDcGc?oc=5","date":"2025-08-06","type":"deal","source":"Pharmaceutical Executive","summary":"SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics for $412 Million - Pharmaceutical Executive","headline":"SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics for $412 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNb05PaldoWGN0enFUV2NzR005OV91aUJ0ZE5makV3VkFqX3NhOHdWMEsyX3FadGlQRlFFVDFhbzhzT2lfb002UnFzR3NwNFJ1OUxNSXM3MDgwXy04NFFNSDFhS204NXo0ZExORmhvRTJ3ckphTkpIYXoza2ZDVm5qLVhYV1JlZXBfN1gxSlVLMXRZSEhx?oc=5","date":"2025-08-05","type":"deal","source":"citybiz","summary":"SERB Pharmaceuticals To Acquire Y-mAbs Therapeutics - citybiz","headline":"SERB Pharmaceuticals To Acquire Y-mAbs Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQTWRqX2dXOGVhYzRWM2pITTZabVg1T0E1UlppUkZpQnJ3UkotOFZ4Vl9STjAyUTJ5aEtYVG54a3ZrRjlPOGxfUDB3MVkxR1JlSFU0cVNYM18zUlJ2a0g5MTRNYWlFUk9CNG9BR1BUbk5VZzdGTEdKRnBpRWt5Q3ZQVWZMeC1MWEFmOE9xeEVTT1hPUEthTUhjZzZQaHJCemVIM3Vv?oc=5","date":"2025-08-05","type":"deal","source":"Stock Titan","summary":"$412M Acquisition: SERB Pharmaceuticals Buys Cancer Drug Maker Y-mAbs at 105% Premium - Stock Titan","headline":"$412M Acquisition: SERB Pharmaceuticals Buys Cancer Drug Maker Y-mAbs at 105% Premium","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPY1FTVVYtdF9vYnZ4VHF1WUFSaDA1M2tGMGNmNlYwbG5yS2lVMFFNclZRS3N0WXBTQS1YLVZLWlVFUHc0R01YTEVQQWJPRFE1Y3ZycWhuSm1IZ21VRHVYRTJITlZmeVpiREJveHk5QVcybHBUYy14UjU1ZUt5SHllYTdVWVQyRUxxTkFrNl9wQk81ekhleXk3MjFR?oc=5","date":"2025-08-05","type":"pipeline","source":"Fierce Pharma","summary":"Y-mAbs signs off on $412M sale to SERB Pharmaceuticals, sending shares up 100% - Fierce Pharma","headline":"Y-mAbs signs off on $412M sale to SERB Pharmaceuticals, sending shares up 100%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNTS1HOHpTZVBNQ1R4ajRtQi1UbmJvWkVwVUJSS1ZwRTdibDBTcnhBM1lKY09XMkJsQW9MR0dsbHQzc1ZYTGNSa3hIaERBWHZxUjYyLU54b0lVaU12aThMcTJYVXo2alV4Q3oxQ1hIMldoVm92MjByWFBBSUY4ekJyb19Hc1U3b3ZsbUdXanJMcVZqUmllbVp6bENBWmlNSW8yTE91RjRrWXhvejdEMXoxMjh2X2RLRXVlSUFuZzJJLWp2MVZOR1lZ?oc=5","date":"2025-08-05","type":"pipeline","source":"Investing.com","summary":"Y-mAbs stock soars after SERB Pharmaceuticals announces acquisition - Investing.com","headline":"Y-mAbs stock soars after SERB Pharmaceuticals announces acquisition","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}